Pamt Corp (PAMT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for October 31, 2024, to vote on key proposals including director elections, a new equity incentive plan, redomestication to Nevada, an increase in authorized shares, and auditor ratification.
Board recommends approval of all proposals, emphasizing governance flexibility, cost savings, and alignment with shareholder interests.
Shareholders of record as of September 5, 2024, are eligible to vote; proxy materials are available online.
Voting matters and shareholder proposals
Proposals include electing nine directors, approving the 2024 Equity Incentive Plan, redomestication to Nevada, increasing authorized common stock to 100 million shares, and ratifying Grant Thornton LLP as auditor.
Board recommends voting “FOR” all proposals; abstentions and broker non-votes count as votes against certain proposals.
Shareholder proposals for the 2025 meeting must comply with advance notice and SEC rules.
Board of directors and corporate governance
Board consists of nine members, with four meeting NASDAQ independence standards; company qualifies as a “controlled company” under NASDAQ rules.
Board structure separates Chairman and CEO roles; active risk oversight through committees.
Three standing committees: Audit, Compensation, and Executive; no separate nominating committee.
Board diversity matrix disclosed; code of ethics applies to all directors, officers, and employees.
Latest events from Pamt Corp
- 2025 net loss deepened on lower revenues and a major auto-liability settlement; liquidity remains sufficient.PAMT
Q4 202512 Mar 2026 - Proxy seeks approval for director elections, equity plan, redomestication, share increase, and auditor.PAMT
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, equity plan, redomestication, and auditor ratification.PAMT
Proxy Filing2 Dec 2025 - Board seeks approval for director slate, auditor ratification, and highlights new equity plan.PAMT
Proxy Filing2 Dec 2025 - Net loss of $5.6M in Q3 and 17.7% revenue drop as operating ratios worsened.PAMT
Q3 20255 Nov 2025 - Revenue and profitability declined sharply in Q2 2025 amid persistent industry headwinds.PAMT
Q2 20258 Aug 2025 - Q3 2024 revenue and net income declined, but management expects market recovery.PAMT
Q3 202413 Jun 2025 - Net loss of $2.9M and 11.8% revenue drop as cost pressures and market headwinds persisted.PAMT
Q2 202413 Jun 2025 - Q1 2025 net loss of $8.1M on 14.9% lower revenue; industry risks remain.PAMT
Q1 20256 Jun 2025